← Open Payments lookup

NATALIE BRADSHAW: Open Payments

NPI 1871275024 · FLORENCE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,188 in 112 payments from 25 companies in 2025. Trend: 2023 $205 · 2024 $1,180 · 2025 $2,188

Food & beverage: $2,183Education: $4
CompanyPaymentsAmount
Corcept Therapeutics23$317
Lilly USA, LLC17$291
Bayer Healthcare Pharmaceuticals Inc.12$266
Novo Nordisk Inc12$208
Astellas Pharma US Inc3$149
Xeris Pharmaceuticals, Inc.5$116
AstraZeneca Pharmaceuticals LP6$102
Tandem Diabetes Care, Inc.6$102
RGH Enterprises LLC1$93
Esperion Therapeutics, Inc.5$78

Products named: Korlym, Kerendia, MOUNJARO, Veozah, RECORLEV, FARXIGA, t:slim X2 Insulin Pump with Control-IQ, NEXLETOL.

Industry payments across MS — which companies pay providers there.